Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Medical oncology].

M S Aapro1

  • 1IMO, Clinique de Genolier, 1272 Genolier. maapro@genolier.net

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary

Recent advances in medical oncology offer improved treatments for solid tumors. However, survival benefits vary, and rising drug costs challenge clinical adoption of promising new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

[Society face to cancer: awareness and social actions].

Revue medicale suisse·2015
Same author

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Cancer treatment reviews·2012
Same author

What do prescribers think of biosimilars?

Targeted oncology·2012
Same author

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

European journal of cancer (Oxford, England : 1990)·2010

Area of Science:

  • Oncology
  • Clinical Trials
  • Pharmacology

Context:

  • Rapid advancements in medical oncology are yielding new drugs for solid tumors.
  • Comparative trials are evaluating the efficacy of these novel therapeutic agents.
  • The clinical utility of some new cancer drugs is questioned due to marginal survival benefits and high costs.

Purpose:

  • To review the results of pivotal clinical trials in medical oncology.
  • To provide a clinically relevant context for interpreting trial data.
  • To aid clinicians in decision-making regarding the use of new cancer drugs.

Summary:

  • This review synthesizes findings from key clinical trials involving new drugs for solid tumors.
  • It highlights areas where significant survival improvements have been observed and where progress remains limited.
  • Data is presented to assist clinicians in assessing the value of promising, yet costly, oncologic therapies.

Impact:

  • Facilitates informed clinical decision-making in the management of solid tumors.
  • Addresses the challenge of integrating expensive novel therapies into patient care.
  • Contributes to a better understanding of the real-world benefits of recent oncologic drug development.

Related Experiment Videos